Literature DB >> 29208145

SurvNet@RKI - a multistate electronic reporting system for communicable diseases.

D Faensen1, H Claus1, J Benzler1, A Ammon1, T Pfoch1, T Breuer1, G Krause1.   

Abstract

In 2001 Germany implemented a new electronic reporting system for surveillance of notifiable infectious diseases (SurvNet@RKI). The system is currently being used in all 431 local health departments (LHD), the 16 state health departments (SHD) and the Robert Koch-Institut (RKI), the national agency for infectious disease epidemiology. The SurvNet@RKI software is written in MS Access 97 and Visual Basic and it supports MS Access as well as MS SQL Server database management systems as a back-end. The database is designed as a distributed, dynamic database for 73 reporting categories with more than 600 fields and about 7000 predefined entry values. An integrated version management system documents deletion, undeletion, completion and correction of cases at any time and entry level and allows reproduction of previously conducted queries. Integrated algorithms and help functions support data quality and the application of case definitions. RKI makes the system available to all LHDs and SHDs free of charge. RKI receives an average of 300 000 case reports and 6240 outbreak reports per year through this system. A public web-based query interface, SurvStat@RKI, assures extensive and timely publication of the data. During the 5 years that SurvNet@RKI has been running in all LHDs and SHDs in Germany it has coped well with a complex federal structure which makes this system particularly attractive to multinational surveillance networks. The system is currently being migrated to Microsoft C#/.NET and transport formats in XML. Based on our experiences, we provide recommendations for the design and implementation of national or international electronic surveillance systems.

Entities:  

Keywords:  surveillance

Year:  2006        PMID: 29208145     DOI: 10.2807/esm.11.04.00614-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  10 in total

1.  Invasive Haemophilus influenzae Infections in Germany After the Introduction of Routine Childhood Immunization, 2001-2016.

Authors:  Anja Takla; Viktoria Schönfeld; Heike Claus; Manuel Krone; Matthias An der Heiden; Judith Koch; Ulrich Vogel; Ole Wichmann; Thiên-Trí Lâm
Journal:  Open Forum Infect Dis       Date:  2020-09-18       Impact factor: 3.835

2.  Australia's National Notifiable Diseases Surveillance System 1991-2011: expanding, adapting and improving.

Authors:  K B Gibney; A C Cheng; R Hall; K Leder
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

3.  Find and treat or find and lose? Tuberculosis treatment outcomes among screened newly arrived asylum seekers in Germany 2002 to 2014.

Authors:  Anna Kuehne; Barbara Hauer; Bonita Brodhun; Walter Haas; Lena Fiebig
Journal:  Euro Surveill       Date:  2018-03

4.  COVID-19: cross-border contact tracing in Germany, February to April 2020.

Authors:  Inessa Markus; Gyde Steffen; Raskit Lachmann; Adine Marquis; Timm Schneider; Sara Tomczyk; Uwe Koppe; Anna M Rohde; Susanne Barbara Schink; Janna Seifried; Teresa Domaszewska; Ute Rexroth; Maria An der Heiden
Journal:  Euro Surveill       Date:  2021-03

5.  Toward an Integrated Genome-Based Surveillance of Salmonella enterica in Germany.

Authors:  Laura Uelze; Natalie Becker; Maria Borowiak; Ulrich Busch; Alexandra Dangel; Carlus Deneke; Jennie Fischer; Antje Flieger; Sabrina Hepner; Ingrid Huber; Ulrich Methner; Jörg Linde; Michael Pietsch; Sandra Simon; Andreas Sing; Simon H Tausch; Istvan Szabo; Burkhard Malorny
Journal:  Front Microbiol       Date:  2021-02-10       Impact factor: 5.640

Review 6.  [Adaptation of the routine surveillance system for infectious diseases in 2020 in the context of the COVID-19 pandemic].

Authors:  Michaela Diercke; Hermann Claus; Ute Rexroth; Osamah Hamouda
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-04-13       Impact factor: 1.513

7.  Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020.

Authors:  Alexander Ullrich; Madlen Schranz; Ute Rexroth; Osamah Hamouda; Lars Schaade; Michaela Diercke; T Sonia Boender
Journal:  Lancet Reg Health Eur       Date:  2021-06-19

8.  Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019.

Authors:  Anja von Laer; Tim Eckmanns; Benedikt Zacher; Niels Pfennigwerth; Sören G Gatermann; Felix Reichert; Michaela Diercke; Gyde Steffen; Doris Altmann; Annicka Reuss
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-04       Impact factor: 4.887

9.  Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data.

Authors:  Djin-Ye Oh; Silke Buda; Barbara Biere; Janine Reiche; Frank Schlosser; Susanne Duwe; Marianne Wedde; Max von Kleist; Martin Mielke; Thorsten Wolff; Ralf Dürrwald
Journal:  Lancet Reg Health Eur       Date:  2021-06-07

10.  Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

Authors:  A von Laer; M Diercke; M An der Heiden; D Altmann; R Zimmermann; S Dudareva
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.